Description
Buy Authentic Mazdutide 10mg Online
Mazdutide 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
What Mazdutide 10mg is
Mazdutide is an investigational peptide that acts as a dual agonist of the GLP-1 receptor and the glucagon receptor GCGR. It’s also known as IBI362. The “10mg” refers to lyophilized powder per vial for research use. It was designed to combine appetite suppression from GLP-1R activation with increased energy expenditure from GCGR activation. It is not FDA-approved and is sold strictly as a research chemical.
Key Product Details Of Mazdutide 10mg
- Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
- Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
- Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
- Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
Research Documentation Context
- Supports compound characterization in controlled laboratory settings.
- Provides batch-specific identity and purity documentation for research review.
- Allows lot-level traceability across laboratory documentation workflows.
- Supports comparison of product labeling, analytical documentation, and storage information during research planning.
- Supports analytical review of receptor-pathway research materials within a strictly laboratory-focused context.
Specifications and Documentation
- Certificate of Analysis: Available with batch-specific documentation where applicable.
- Material Safety Data Sheet: Coming Soon.
- Handling and Storage Instructions: Coming Soon.
- Product Form: Lyophilized powder.
- Purity Specification: ≥99% purity.
- Intended Use: Laboratory research use only.
Mazdutide 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
How researchers study it
In preclinical and clinical models, Mazdutide is used to investigate obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease MASH/NASH. GLP-1R activity helps with glucose control, satiety, and slower gastric emptying. GCGR activity may increase hepatic fat oxidation and energy expenditure. Researchers measure endpoints like body weight, HbA1c, liver fat by MRI-PDFF, insulin sensitivity, and lipid profiles in rodent and human trials.
Why it got research attention
Dual GLP-1/GCGR agonists became a focus after single-agent GLP-1 drugs showed strong weight and glucose benefits. The idea is that adding balanced glucagon signaling could add fat-burning effects without major hyperglycemia. Innovent Biologics has sponsored Phase 2 and Phase 3 trials of Mazdutide in China for obesity and T2D. Published Phase 2 data showed dose-dependent weight reduction and improvements in liver enzymes and liver fat, similar in concept to Survodutide and retatrutide but with a different receptor ratio.
Form, purity & handling
Mazdutide 10mg for research typically comes as a white, freeze-dried powder in a sterile vial. Reputable suppliers provide a COA with HPLC and mass spec confirming peptide sequence and purity, usually >95% for research grade. Peptides degrade with heat, light, and moisture. Store at -20°C or -80°C after reconstitution. The clinical trial drug product is a separate, GMP formulation and not available commercially.
Legal + safety status
Mazdutide is not FDA-approved for any indication. It’s labeled “for research use only, not for human consumption.” It remains in clinical development and is not an approved drug. There is no established human dosing outside trials, no long-term safety data, and no proven clinical benefit yet. As with other incretin-based peptides, adverse effects studied in trials have included GI symptoms, injection site reactions, and changes in heart rate. It’s banned for use in sports by WADA if used as a performance agent.
Bottom line
*Mazdutide 10mg* is an investigational research peptide used to study dual GLP-1R/GCGR agonism for metabolic disease. Early trial results suggest potential for weight loss and liver fat reduction, but it has no regulatory approval. *No peptide is a substitute for FDA-approved therapies or evidence-based medical care.* For weight, diabetes, or liver health concerns, talk to a licensed healthcare provider about approved GLP-1 drugs, lifestyle interventions, and therapies with proven clinical data.
